 |
|
A
unique benefit to patients at the Stehlin &
deIpolyi Oncology Clinic is their immediate and
ongoing access to the research being conducted
at the CHRISTUS Stehlin Foundation for Cancer Research,
located in its own 18,000 square foot facility
on the 12 city block campus of St. Joseph Hospital
in the heart of downtown Houston.
|
| Patients
are not charged for these studies, but have immediate
access to new treatment protocols developed as a
result of this patient-focused research and treatment. |
|
|
Physicians
at the Stehlin & deIpolyi Oncology Clinic
strive to deliver the highest quality personalized
care to our patients.
|
|
|
|
At
the Stehlin & deIpolyi Oncology Clinic, we have been dispensing
hope for more than a quarter of a century.
|
|
We believe
that most major cancers are best treated by a multi-disciplinary
approach which may include surgery, radiation therapy, chemotherapy,
immunotherapy, and hyperthermia. More |
|
 |
 |
|
|
Dr. Joseph Rubinfeld, chairman and CEO of SuperGen said,
"Rubitecan (9NC) is the most important drug in our
broad pipeline, as well as our most advanced and top-priority
clinical project. Due to the lack of effective treatment
for pancreatic cancer patients, we are taking every step
possible to accelerate our Phase III trial in order to
be in position to submit a New Drug Application to the
FDA as quickly as possible." More |
|
Our
physicians and scientists share their innovative treatment
methods and research discoveries through articles in top
national and international scientific publications. Our
staff also provide seminars to major corporations and
civic organizations. More |
|
We
ensure continuity of care by having one physician in charge
of the patient throughout his or her entire course of
treatment. Patients are not tied to a single protocol;
rather, the treating physician selects the best therapy
for the individual patient, consulting with other staff
clinicians and health care professionals as required for
the patient’s total care. More |
|
|
|
|
